Outpatient palliative care specialist referral patterns among patients with gynecological cancers

Background: Outpatient palliative care specialists remain underutilized in high-resource settings despite evidence demonstrating benefits in quality-of-life and symptom burden with early referral. The objective of this single institution retrospective cohort study was to develop a method to evaluate palliative care (PC) referral patterns to assess compliance with recently updated American Society of Clinical Oncology (ASCO) guidelines. Methods: Patients with gynecological cancers with advanced or recurrent disease seen in gynecologic oncology clinic from 2019–2022 were identified by Current Procedural Terminology (CPT) code and an institutional palliative care referral database. Demographics, referral source and utilization metrics were collected. Outcomes included rates of palliative care referral of eligible patients, referral completion and time from referral to first palliative care visit, hospice enrollment and/or death. Results: 434 patients with gynecological cancers met ASCO criteria for outpatient palliative care specialist referral. 192 of 434 (44%) were referred to palliative care and 147 of 192 (76.5%) saw a palliative care provider. 78% were referred by gynecologic oncology, 12% were referred by palliative care at hospital discharge and 8% were referred by medical or radiation oncology. Median time from referral to appointment was 20 days (interquartile range (IQR) 12–29 days). Patients did not utilize palliative care most commonly due to hospice enrollment (44%), patient preference (41%) and unable to be contacted (9%). Median time from referral to hospice enrollment was 112 days (IQR 30–329 days), and median time from hospice enrollment to death was 18 days (IQR 9–38 days). Conclusions: Fewer than half of patients with advanced or recurrent gynecological cancers were referred to outpatient palliative care specialists. Most referrals were completed within thirty days. Institutions can evaluate compliance with ASCO guidelines for palliative care uptake using a multi-pronged approach leveraging billing data and administrative databases to design strategic interventions for quality improvement.

Palliative care; Quality improvement; Quality-of-life

[1] Temel JS, Greer JA, Muzikansky A, Gallagher ER, Admane S, Jackson VA, et al. Early palliative care for patients with metastatic non-small-cell lung cancer. The New England Journal of Medicine. 2010; 363: 733–742.

[2] Bakitas MA, Tosteson TD, Li Z, Lyons KD, Hull JG, Li Z, et al. Early versus delayed initiation of concurrent palliative oncology care: patient outcomes in the ENABLE III randomized controlled trial. Journal of Clinical Oncology. 2015; 33: 1438–1445.

[3] Zimmermann C, Swami N, Krzyzanowska M, Hannon B, Leighl N, Oza A, et al. Early palliative care for patients with advanced cancer: a cluster-randomised controlled trial. The Lancet. 2014; 383: 1721–1730.

[4] Lefkowits C, Teuteberg W, Courtney-Brooks M, Sukumvanich P, Ruskin R, Kelley JL. Improvement in symptom burden within one day after palliative care consultation in a cohort of gynecologic oncology inpatients. Gynecologic Oncology. 2015; 136: 424–428.

[5] Ruskin R, Rabow MW, Allen IE, Chen LM. Outpatient palliative care consultation is associated with a decrease in symptom burden for women with gynecologic malignancies. Gynecologic Oncology. 2014; 133: 45.

[6] Gil-Ibanez B, Tejerizo-Garcia A, Oliver MR, Madariaga A, Maiz Jimenez M, Gil Garcia A, et al. Side effects screening and early intervention to impact in quality of life of patients with gynecological cancers (HALIS study). International Journal of Gynecological Cancer. 2023; 33: 1645–1648.

[7] Tabuyo-Martin A, Torres-Morales A, Pitteloud MJ, Kshetry A, Oltmann C, Pearson JM, et al. Palliative medicine referral and end-of-life interventions among racial and ethnic minority patients with advanced or recurrent gynecologic cancer. Cancer Control. 2023; 30: 10732748231157191.

[8] Buras AL, Barkhurst M, Rutherford TJ, Anderson ML, English DP. The intersection of palliative care and genetic counseling in cancer care: a case discussion. Journal of Palliative Medicine. 2022; 25: 167–171.

[9] Joost K, Washington K, Faurot M, Alexander RL, Craig KW, Tuller ER. Identifying the palliative care needs of patients and families in gynecologic surgical oncology: a scoping review. Journal of Psychosocial Oncology. 2023; 41: 732–743.

[10] Krakauer EL, Kwete X, Kane K, Afshan G, Bazzett-Matabele L, Bien-Aimé DDR, et al. Cervical cancer-associated suffering: estimating the palliative care needs of a highly vulnerable population. JCO Global Oncology. 2021; 7: 862–872.

[11] Krakauer EL, Kane K, Kwete X, Afshan G, Bazzett-Matabele L, Ruthnie Bien-Aimé DD, et al. Augmented package of palliative care for women with cervical cancer: responding to refractory suffering. JCO Global Oncology. 2021; 7: 886–895.

[12] Khoo T, Karlin D, Pietras C. Updates in palliative care of gynecologic oncology patients. Current Opinion in Obstetrics and Gynecology. 2025; 37: 1–4.

[13] Shinall MC Jr, Martin SF, Karlekar M, Hoskins A, Morgan E, Kiehl A, et al. Effects of specialist palliative care for patients undergoing major abdominal surgery for cancer: a randomized clinical trial. JAMA Surgery. 2023; 158: 747–755.

[14] Ferrell BR, Temel JS, Temin S, Smith TJ. Integration of palliative care into standard oncology care: ASCO clinical practice guideline update summary. Journal of Oncology Practice. 2017; 13: 119–121.

[15] Levy M, Smith T, Alvarez-Perez A, Back A, Baker JN, Beck AC, et al. Palliative care version 1.2016. Journal of the National Comprehensive Cancer Network. 2016; 14: 82–113.

[16] Delivery of palliative care services. 2012. Available at: https://www.sgo.org/resources/delivery-of-palliative-care-services/ (Accessed: 06 December 2024).

[17] Peters PN, Havrilesky LJ, Davidson BA. Guidelines for goals of care discussions in patients with gynecologic cancer. Gynecologic Oncology. 2023; 174: 247–252.

[18] Hsieh A, Gien LT. Timing of palliative care initiation and resource use-are we any further ahead? JAMA Network Open. 2024; 7: e2440902.

[19] Fujiwara K, Connor SR, Fujiwara N, Correa R, Mburu A, Leopold D, et al. The international gynecologic cancer society consensus statement on palliative care. International Journal of Gynecological Cancer. 2024; 34: 1128–1132.

[20] Peters PN, Moyett JM, Wolf SP, Troy J, Wang H, Zhou S, et al. Moving beyond “Better Late Than Never”: high symptom burden and diminished functional status at first palliative care visit for patients with gynecological cancers. Journal of Palliative Medicine. 2024; 27: 1204–1209.

[21] Lee MW, Sriprasert I, Phung PG, Pino C, Woll SM, Vallejo A, et al. Trends and comparisons of palliative care utilization for patients with metastatic gynecologic malignancy. International Journal of Gynecological Cancer. 2025; 35: 101631.

[22] Nevadunsky NS, Gordon S, Spoozak L, Van Arsdale A, Hou Y, Klobocista M, et al. The role and timing of palliative medicine consultation for women with gynecologic malignancies: association with end of life interventions and direct hospital costs. Gynecologic Oncology. 2014; 132: 3–7.

[23] Nitecki R, Diver EJ, Kamdar MM, Boruta DM 2nd, Del Carmen MC, Clark RM, et al. Patterns of palliative care referral in ovarian cancer: A single institution 5 year retrospective analysis. Gynecologic Oncology. 2018; 148: 521–526.

[24] Bercow AS, Nitecki R, Haber H, Gockley AA, Hinchcliff E, James K, et al. Palliative care referral patterns and measures of aggressive care at the end of life in patients with cervical cancer. International Journal of Gynecological Cancer. 2021; 31: 66–72.

[25] Zivanov CN, Coogan A, Lane RR, Lin SG, Reed SC, Robinson MA, et al. A letter to your care providers: implementation and analysis of a letter-based advance care planning initiative for gynecologic oncology patients. Journal of Cancer Education. 2023; 38: 963–970.

[26] Smith CB, Phillips T, Smith TJ. Using the new ASCO clinical practice guideline for palliative care concurrent with oncology care using the TEAM approach. American Society of Clinical Oncology Educational Book. 2017; 37: 714–723.

[27] Haag JG, Adler AD, Sheeder J, Brubaker LW, Lefkowits C. Patterns of palliative care referral in platinum resistant ovarian cancer demonstrate reactive rather than proactive approach. Gynecologic Oncology Reports. 2022; 43: 101053.

[28] Cusimano MC, Sajewycz K, Harle I, Giroux J, Hanna T, Willing S, et al. Acceptability and feasibility of early palliative care among women with advanced epithelial ovarian cancer: a randomized controlled pilot study. Journal of Obstetrics and Gynaecology Canada. 2021; 43: 707–715.

[29] Dillon EC, Chopra V, Mesghina E, Milki A, Chan A, Reddy R, et al. The healthcare journey of women with advanced gynecological cancer from diagnosis through terminal illness: qualitative analysis of progress note data. American Journal of Hospice and Palliative Medicine. 2022; 39: 1090–1097.

[30] Mah SJ, Carter Ramirez DM, Eiriksson LR, Schnarr K, Gayowsky A, Seow H. Palliative care utilization across health sectors for patients with gynecologic malignancies in Ontario, Canada from 2006 to 2018. Gynecologic Oncology. 2023; 175: 169–175.

[31] Sanders JJ, Temin S, Ghoshal A, Alesi ER, Ali ZV, Chauhan C, et al. Palliative care for patients with cancer: ASCO guideline update. Journal of Clinical Oncology. 2024; 42: 2336–2357.

[32] Ratnaparkhi R, Spoozak L. When insight yields inaction: the role of implementation science in improving palliative care integration. Annals of Palliative Medicine. 2023; 12: 274–279.

[33] Vetter VJ. Palliative care screening tools in the gynecologic oncology population: a narrative review. Annals of Palliative Medicine. 2022; 11: 3263–3272.

[34] Barton W, Cohen M, Raker C, Luis C, Cram R, Mendez H, et al. The surprise question in gynecologic oncology: an analysis looking at end-of-life care in patients with gynecologic cancer. Gynecologic Oncology. 2020; 159: 313.

[35] Rauh LA, Sullivan MW, Camacho F, Janke MJ, Duska LR, Chandler C, et al. Validation of the surprise question in gynecologic oncology: A one-question screen to promote palliative care integration and advance care planning. Gynecologic Oncology. 2020; 157: 754–758.

[36] Paiva CE, Paiva BSR, Menezes D, Zanini LE, Ciorlia JB, Miwa MU, et al. Development of a screening tool to improve the referral of patients with breast and gynecological cancer to outpatient palliative care. Gynecologic Oncology. 2020; 158: 153–157.

[37] Zimmermann C, Pope A, Hannon B, Krzyzanowska MK, Rodin G, Li M, et al. Phase II trial of symptom screening with targeted early palliative care for patients with advanced cancer. Journal of the National Comprehensive Cancer Network. 2021; 20: 361–370.e363.

[38] Gressel GM, Dioun SM, Richley M, Lounsbury DW, Rapkin BD, Isani S, et al. Utilizing the patient reported outcomes measurement information system (PROMIS®) to increase referral to ancillary support services for severely symptomatic patients with gynecologic cancer. Gynecologic Oncology. 2019; 152: 509–513.

[39] Feder SL, Zhan Y, Abel EA, Smith D, Ersek M, Fried T, et al. Validation of electronic health record-based algorithms to identify specialist palliative care within the department of veterans affairs. Journal of Pain and Symptom Management. 2023; 66: e475–e483.

[40] Gajra A, Jeune-Smith Y, Balanean A, Miller KA, Bergman D, Showalter J, et al. Reducing avoidable emergency visits and hospitalizations with patient risk-based prescriptive analytics: a quality improvement project at an oncology care model practice. JCO Oncology Practice. 2023; 19: e725–e731.

[41] Schierenbeck SJ, Elertson K. Effect of a palliative care screening tool for oncology patients. Journal of Hospice & Palliative Nursing. 2022; 24: 119–124.

[42] Lee RY, Brumback LC, Lober WB, Sibley J, Nielsen EL, Treece PD, et al. Identifying goals of care conversations in the electronic health record using natural language processing and machine learning. Journal of Pain and Symptom Management. 2021; 61: 136–142.e132.

[43] Ferrell BR, Temel JS, Temin S, Alesi ER, Balboni TA, Basch EM, et al. Integration of palliative care into standard oncology care: American society of clinical oncology clinical practice guideline update. Journal of Clinical Oncology. 2017; 35: 96–112.

[44] Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)—a metadata-driven methodology and workflow process for providing translational research informatics support. Journal of Biomedical Informatics. 2009; 42: 377–381.

[45] Harris PA, Taylor R, Minor BL, Elliott V, Fernandez M, O’Neal L, et al. The REDCap consortium: Building an international community of software platform partners. Journal of Biomedical Informatics. 2019; 95: 103208.

[46] Divisi D, Di Leonardo G, Zaccagna G, Crisci R. Basic statistics with Microsoft Excel: a review. Journal of Thoracic Disease. 2017; 9: 1734–1740.

[47] von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP; STROBE Initiative. Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. The BMJ. 2007; 335: 806–808.

[48] Grogan L, Peterson E, Flatley M, Domeyer-Klenske A. Impact of patient safety bundle and team-based training on obstetric hypertensive emergencies. American Journal of Perinatology. 2025; 42: 452–461.

[49] Buckley de Meritens A, Margolis B, Blinderman C, Prigerson HG, Maciejewski PK, Shen MJ, et al. Practice patterns, attitudes, and barriers to palliative care consultation by gynecologic oncologists. Journal of Oncology Practice. 2017; 13: e703–e711.

[50] Cripe JC, Mills KA, Kuroki LK, Wan L, Hagemann AR, Fuh KC, et al. Gynecologic oncologists’ perceptions of palliative care and associated barriers: a survey of the society of gynecologic oncology. Gynecologic and Obstetric Investigation. 2019; 84: 50–55.

[51] Hmaidan S, Goulder A, Bos L, Shen MJ, Wellman JD, Prescott L, et al. Too close for comfort? Attitudes of gynecologic oncologists toward caring for dying patients. American Journal of Hospice and Palliative Medicine. 2023; 40: 1168–1173.

[52] Hay CM, Lefkowits C, Crowley-Matoka M, Bakitas MA, Clark LH, Duska LR, et al. Gynecologic oncologist views influencing referral to outpatient specialty palliative care. International Journal of Gynecological Cancer. 2017; 27: 588–596.

[53] Islam JY, Saraiya V, Previs RA, Akinyemiju T. Health care access measures and palliative care use by race/ethnicity among metastatic gynecological cancer patients in the united states. International Journal of Environmental Research and Public Health. 2021; 18: 6040.

[54] Conley CC, Buras AL, McIntyre M, Santiago-Datil W, English D, Wenham RM, et al. “It doesn’t really apply to what I’m going through”: a mixed-methods study of barriers to palliative care among patients with advanced ovarian cancer. Supportive Care in Cancer. 2023; 31: 397.

[55] Pozzar RA, Enzinger AC, Howard C, Tavormina A, Matulonis UA, Campos S, et al. Feasibility and acceptability of a nurse-led telehealth intervention (bolster) to support patients with peritoneal carcinomatosis and their caregivers: a pilot randomized clinical trial. Gynecologic Oncology. 2024; 188: 1–7.

[56] Nair N, Schlumbrecht M. Existing health inequities in the treatment of advanced and metastatic cancers. Current Oncology Reports. 2024; 26: 1553–1562.

[57] Hoppenot C. Palliative care is a critical part of gynecologic oncologic care. Annals of Palliative Medicine. 2023; 12: 25–27.

[58] Hui D, De La Rosa A, Bruera E. State of integration of palliative care at national cancer institute-designated and nondesignated cancer centers. JAMA Oncology. 2020; 6: 1292–1295.

[59] Hui D, Anderson L, Tang M, Park M, Liu D, Bruera E. Examination of referral criteria for outpatient palliative care among patients with advanced cancer. Supportive Care in Cancer. 2020; 28: 295–301.

[60] Hui D, Meng YC, Bruera S, Geng Y, Hutchins R, Mori M, et al. Referral criteria for outpatient palliative cancer care: a systematic review. The Oncologist. 2016; 21: 895–901.

[61] Hui D, Heung Y, Bruera E. Timely palliative care: personalizing the process of referral. Cancers. 2022; 14: 1047.

[62] Hui D, Mori M, Watanabe SM, Caraceni A, Strasser F, Saarto T, et al. Referral criteria for outpatient specialty palliative cancer care: an international consensus. The Lancet Oncology. 2016; 17: e552–e559.

[63] Glare PA, Semple D, Stabler SM, Saltz LB. Palliative care in the outpatient oncology setting: evaluation of a practical set of referral criteria. Journal of Oncology Practice. 2011; 7: 366–370.

[64] Singh S, Rodriguez A, Lee D, Min SJ, Fischer S. Usefulness of the surprise question on an inpatient oncology service. American Journal of Hospice and Palliative Medicine. 2018; 35: 1421–1425.

[65] Mittmann N, Liu N, MacKinnon M, Seung SJ, Look Hong NJ, Earle CC, et al. Does early palliative identification improve the use of palliative care services? PLOS One. 2020; 15: e0226597.

[66] Lefkowits C, Courtney-Brooks M, Teuteberg W, Leahy J, Sukumvanich P, Kelley JL. Clinical triggers for inpatient palliative care consultation in gynecologic oncology: a needs assessment. Gynecologic Oncology. 2014; 133: 53.

[67] Lefkowits C, Courtney-Brooks M, Teuteberg W, Leahy J, Sukumvanich P, Kelley JL. Implementation of clinical triggers for palliative care consultation on a gynecologic oncology inpatient service: a pilot study. Journal of Clinical Oncology. 2014; 32: 51.

[68] Hui D, Titus A, Curtis T, Ho-Nguyen VT, Frederickson D, Wray C, et al. Implementation of the Edmonton symptom assessment system for symptom distress screening at a community cancer center: a pilot program. The Oncologist. 2017; 22: 995–1001.

[69] Iqbal J, Sutradhar R, Zhao H, Howell D, O’Brien MA, Seow H, et al. Operationalizing outpatient palliative care referral criteria in lung cancer patients: a population-based cohort study using health administrative data. Journal of Palliative Medicine. 2020; 23: 670–677.

[70] Schneiter MK, Karlekar MB, Crispens MA, Prescott LS, Brown AJ. The earlier the better: the role of palliative care consultation on aggressive end of life care, hospice utilization, and advance care planning documentation among gynecologic oncology patients. Supportive Care in Cancer. 2019; 27: 1927–1934.

[71] Lefkowits C, Binstock AB, Courtney-Brooks M, Teuteberg WG, Leahy J, Sukumvanich P, et al. Predictors of palliative care consultation on an inpatient gynecologic oncology service: are we following ASCO recommendations? Gynecologic Oncology. 2014; 133: 319–325.

[72] Hui D, Mori M, Meng YC, Watanabe SM, Caraceni A, Strasser F, et al. Automatic referral to standardize palliative care access: an international Delphi survey. Supportive Care in Cancer. 2018; 26: 175–180.

[73] Strachna O, Asan O, Stetson PD. Managing critical patient-reported outcome measures in oncology settings: system development and retrospective study. JMIR Medical Informatics. 2022; 10: e38483.

[74] Srilatha B, Sundararaj JJ, D N S, Prasoona TS, Joseph J, Celine T, et al. Palliative care outpatients and improved documentation-what matters most? Quality improvement project. BMJ Supportive & Palliative Care. 2024; 14: e2950–e2953.

[75] Salyer C, Littell RD, Pearl ML, Brown AJ, Popowich S, Lefkowits C, et al. Palliative care in gynecologic oncology: a narrative review of current literature and vision for the future. Annals of Palliative Medicine. 2022; 11: 3542–3554.

[76] Ben-Arye E, Mao J, Bruera E, Samuels N, Keshet Y, Lee RT, et al. Challenges in implementing guideline on integrative oncology and pain: the Israeli perspective. Journal of Pain and Symptom Management. 2024; 67: 69–76.

[77] Osborne SM, Kim C, Levit EM, Marko EK, Roche-Green A, Hunter BD, et al. A longitudinal, multimodal palliative care curriculum for obstetrics and gynecology residents. Palliative & Supportive Care. 2025; 23: e39.

[78] Brubaker LW, Moroney MR, Thannickal A, Alston MJ, Amory JH, Kumar A, et al. Design, implementation, and evaluation of a multidisciplinary palliative care curriculum for obstetrician gynecologist residents. Palliative Medicine Reports. 2025; 6: 90–97.

[79] Persenaire C, Spinosa DL, Brubaker LW, Lefkowits CJ. Incorporation of palliative care in gynecologic oncology. Current Oncology Reports. 2023; 25: 1295–1305.

[80] Lee S, Kim JH, Ha HI, Lim MC, Cho H. Development of an automatic rule-based algorithm for the detection of ovarian cancer recurrence from electronic health records. JCO Clinical Cancer Informatics. 2024; 8: e2300150.

[81] Warren JL, Mariotto A, Melbert D, Schrag D, Doria-Rose P, Penson D, et al. Sensitivity of Medicare claims to identify cancer recurrence in elderly colorectal and breast cancer patients. Medical Care. 2016; 54: e47–e54.

[82] Verschueren MV, Abedian Kalkhoran H, Deenen M, van den Borne BEEM, Zwaveling J, Visser LE, et al. Development and portability of a text mining algorithm for capturing disease progression in electronic health records of patients with stage IV non-small cell lung cancer. JCO Clinical Cancer Informatics. 2024; 8: e2400053.

[83] Chubak J, Yu O, Pocobelli G, Lamerato L, Webster J, Prout MN, et al. Administrative data algorithms to identify second breast cancer events following early-stage invasive breast cancer. Journal of the National Cancer Institute. 2012; 104: 931–940.

[84] Deshpande AD, Schootman M, Mayer A. Development of a claims-based algorithm to identify colorectal cancer recurrence. Annals of Epidemiology. 2015; 25: 297–300.

[85] Warren JL, Yabroff KR. Challenges and opportunities in measuring cancer recurrence in the United States. Journal of the National Cancer Institute. 2015; 107: djv134.

[86] Sewell JM, Rao A, Elliott SP. Validating a claims-based method for assessing severe rectal and urinary adverse effects of radiotherapy. Urology. 2013; 82: 335–340.

[87] Epstein AS, Knezevic A, Romano DR, Hoque A, Raj N, Reidy D, et al. Patient portals to elicit essential patient-reported elements of communication supporting person-centered oncologic care: a pilot study of the PERSON approach. JCO Clinical Cancer Informatics. 2023; 7: e2300125.

[88] Michael CL, Mittelstaedt H, Chen Y, Desai AV, Kuperman GJ. Applying user-centered design in the electronic health record (EHR) to facilitate patient-centered care in oncology. AMIA Annual Symposium Proceedings. 2020; 2020: 833–839.

[89] Desai AV, Agarwal R, Epstein AS, Kuperman GJ, Michael CL, Mittelstaedt H, et al. Needs and perspectives of cancer center stakeholders for access to patient values in the electronic health record. JCO Oncology Practice. 2021; 17: e1524–e1536.

[90] Nekolaichuk C, Watanabe S, Beaumont C. The Edmonton symptom assessment system: a 15-year retrospective review of validation studies (1991–2006). Palliative Medicine. 2008; 22: 111–122.

[91] Richardson LA, Jones GW. A review of the reliability and validity of the Edmonton symptom assessment system. Current Oncology. 2009; 16: 55.

[92] Lau F, Cloutier-Fisher D, Kuziemsky C, Black F, Downing M, Borycki E, et al. A systematic review of prognostic tools for estimating survival time in palliative care. Journal of Palliative Care. 2007; 23: 93–112.

[93] Dudgeon DJ, Knott C, Chapman C, Coulson K, Jeffery E, Preston S, et al. Development, implementation, and process evaluation of a regional palliative care quality improvement project. Journal of Pain and Symptom Management. 2009; 38: 483–495.

[94] Musser RC, Senior R, Havrilesky LJ, Buuck J, Casarett DJ, Ibrahim S, et al. Randomized comparison of electronic health record alert types in eliciting responses about prognosis in gynecologic oncology patients. Applied Clinical Informatics Journal. 2024; 15: 204–211.

[95] Sedhom R, Gupta A, Shah M, Hsu M, Messmer M, Murray J, et al. Oncology fellow-led quality improvement project to improve rates of palliative care utilization in patients with advanced cancer. JCO Oncology Practice. 2020; 16: e814–e822.

[96] Wall JA, Lipking K, Smith HJ, Huh WK, Salter T, Liang MI. Moderate to severe distress in half of ovarian cancer patients undergoing treatment highlights a need for more proactive symptom and psychosocial management. Gynecologic Oncology. 2022; 166: 503–507.

[97] Wulff-Burchfield E, Spoozak L, Finlay E. Palliative chemotherapy and the surgical oncologist. Surgical Oncology Clinics of North America. 2021; 30: 545–561.

[98] Khan AF, Seow H, Sutradhar R, Peacock S, Chan KK, Burge F, et al. Quality of end-of-life cancer care in Canada: a 12-year retrospective analysis of three provinces’ administrative health care data evaluating changes over time. Current Oncology. 2021; 28: 4673–4685.

[99] U.S. Centers for Medicare & Medicaid Services. Quality Measures. 2024. Available at: https://www.cms.gov/medicare/quality/measures (Accessed: 06 December 2024).

[100] Kamal AH, Bausewein C, Casarett DJ, Currow DC, Dudgeon DJ, Higginson IJ. Standards, guidelines, and quality measures for successful specialty palliative care integration into oncology: current approaches and future directions. Journal of Clinical Oncology. 2020; 38: 987–994.

[101] Puranam S, Disalvo D, Giannitrapani K, Lorenz K, Mickelsen J, DeNatale M, et al. Palliative care-promoting and improving clinical excellence (PC-PAICE): bringing a cross border quality improvement (QI) collaborative to Australia. Journal of Pain and Symptom Management. 2025; 70: e28–e33.